Posted: 22 Jan 2019 04:38 PM PST CBI is holding its Fourth Edition Drug Pricing Transparency Congress on March 25-26, 2019 in Philadelphia, Pennsylvania. This program convenes stakeholders to discuss how the future of drug pricing transparency regulations will impact commercialization, reimbursement, pricing, and compliance practices. Given the novelty and complexity of state laws aimed at transparency and reporting of drug pricing information, this will be of particular interest to FDA Law Blog readers. . . . and, importantly, for which our readers can get a discount. Hyman, Phelps & McNamara, P.C.’s David Gibbons will be joining the distinguished faculty of legal and regulatory experts to participate in the State-by-State Analysis Showcase and speak on the current status of Nevada’s SB-539. As a sponsor of the event, we can offer our readers a special $300 discount off the registration. The discount code is: DPC300, which expires February 1st. We look forward to seeing you at this conference. |
No hay comentarios:
Publicar un comentario